Atossa Therapeutics
ATOS
ATOS
52 hedge funds and large institutions have $20.2M invested in Atossa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% less ownership
Funds ownership: 0.86% → 0.84% (-0.02%)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
52
Holding in Top 10
–
Calls
$1.38M
Puts
$91K
Top Buyers
| 1 | +$245K | |
| 2 | +$216K | |
| 3 | +$112K | |
| 4 |
VF
Virtu Financial
New York
|
+$70.2K |
| 5 |
Jane Street
New York
|
+$45.5K |
Top Sellers
| 1 | -$491K | |
| 2 | -$247K | |
| 3 | -$119K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$79.5K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$47.6K |